Hemogenyx Pharmaceuticals Share Discussion Threads

[lunus1] 03/1/2022 08:34

Badger I admit you were right about the CLNs. In fairness I think most ordinary PIs like myself thought that with it getting approved with something like a 99% majority it must be ok. I don’t think it’s that we’re thick, just most like me didn’t read the prospectus until it was way too late and by then the damage was done. Maybe that does make me thick lol.
Anyway, lessons learnt and we move on. Don’t really understand your ongoing negativity and posts on HEMO, especially as you’re not even invested? Still that’s your call. Think most invested now will be looking towards the future rather than ruminating about the past. Let’s see what happens in the coming months. No doubt (for whatever reason) you’ll be with us every step of the way. Happy new year all.

[badger60] 03/1/2022 07:17

Another Groundhog Day coming up here. This has got to be the most boring stock on LSE.....it must be a reflection of its Muppet shareholders..... ain't that right Justaman........

[justaman] 03/1/2022 06:16

I feel privileged

[david gruen] 02/1/2022 19:09

Analysis completed. HEMO is going to rocket soon. Honestly, I mean it. Never been so convinced. I’m talking a break of 16p within the space of a week.

Are we expecting news that would take us to 80-100 million cap?

Truly excited.

Not investment advice of course.

[bahamarama] 01/1/2022 13:27

Happy New Year, Badge...Keep keeping honest those who choose to keep open their eyes and ears.Every disappointing day in the HEMO Club is a day closer to whatever each individual stakes their capital on. The table remains open. And, yes, so far the HOUSE is firmly in control.Prosperity and health I wish for you and all...Cheers...

[badger60] 01/1/2022 11:52

Lunus1Good post.I would strongly disagree agree with you about how much is left in the bank. IMO it's currently nearer to 4-5 Mio.... considering the ongoing cashburn, fees to Penn etc....+ the amounts already payed out after the last set of figures...Ely work and patent fees etc.Anyway hopefully the "partnership" will bear fruit...but I bet that Vlad is putting his hand in the company pocket for that as well.......

[lunus1] 01/1/2022 11:12

Badger Thank you for your kind words. It’s important to emphasize that Hemogenyx is not about me, or you for that matter, and certainly not about Justaman who appears to ramp the company every time he’s caught another falling knife. Apparently everyone with a view that conflicts with his is a child that shouldn’t be trading, and according to him no untruths would ever be said by HEMO.
So let’s look at the facts. I’ll even put aside what they said about Globalco taking up the option and what they said about Mint being long term strategic partners who would not be selling their options. So in 2020 Vlad said they would have at least one product candidate in clinical trials in 2021. They didn’t. Sir Marc said in his Chairman’s statement 2021 would be an inflection point. It wasn’t. Vlad tweeted last February ‘this will be the most exciting year ever for Hemogenyx’. It wasn’t. Vlad stated in April that three CAR-T partners, one ‘a famous name’ would be announced soon’. They weren’t. He stated the appalling share price was ‘a temporary blip’. It wasn’t. He stated in June that CBR would be announced soon, with regular updates to follow. Well, it wasn’t. I could go on but I think people get the point, they have been disingenuous to say the least.
So why do I still hold? Simple really, there are many positives to the company. Firstly they are fully funded to take CAR-T through phase 1 clinical trials. In Feldmann and Shepard they have two individuals who have been there and done it, in bringing two of the top selling drugs in the world to market. In collaboration with Penn they have arguably the world leaders in CAR-T therapy to assist them. Their latest partnership with a multi billion dollar company, manufacturing their own CAR, the move to the new office, the forthcoming FDA meeting, everything tells me this product candidate will progress to clinical trials. With peer level companies valued around £170m it has a great risk vs reward in my opinion. They could also have something special with CBR in this Covid riddled world, a potentially unique solution to all viral diseases. There’s CDX and I think non dilutive funding to take them through Q3 and beyond so lots to be excited about. In summary, they have had a total disregard of shareholders over the last eighteen months or so but could potentially substantially rerate during 2022. Personally I have little trust in what they say and am more interested in what they actually do throughout this coming year. Could be a great earner, might not be. Time will tell. Good luck to all invested. Fingers crossed anyway.

[badger60] 01/1/2022 04:49

Same to you lunus.... hopefully it will be a better one for all than 2021.............;+)ps, CheckRicky the Pikey is now trying to emulate your posting style. as a stock fluffer .Rest assured that despite being blatantly lied to, your posts were eloquently written and under different circumstances would have been very value added to shareholders. In addition, I would be extremely surprised if you were a Neanderthal who wanted to physically threaten dissenters......like me, as does the pikey, Check Ricky.Happy New Year

[davevtsmummy] 31/12/2021 17:22

The only thing badger carries is a handbag, what a nonce.

[badger60] 31/12/2021 14:33

I can just hear your kids( that's if they're yours)......"Why is dad hitting mummy again?" Shall I call the police? Oh.. the life of being a pikey.....

[badger60] 31/12/2021 14:29

Wait til after the New Year...down it goes back to 1.6p...and you know it....

[checkricky] 31/12/2021 14:17

BLAGGER60 No One sold under 1.872p and BUY'S @ 1.95p outstripped any sells all day long

[badger60] 31/12/2021 13:58

Last night's curry.... certainly not you...

[badger60] 31/12/2021 13:48

Ps If you do find me.......where I live we all carry .......

[checkricky] 31/12/2021 13:44

BLAGGER60 No One sold under 1.82p and BUY'S outstripped sells all day long